[ Epic Sciences raises $40M in Series D ]
Epic Sciences has raised $40 million in Series D funding.
Founded in 2008, Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine.
The fund will go to accelerate clinical studies and enhance the Epic Sciences’s technology.
|City||La Jolla, California|
|Founder / CEO||Murali K. Prahalad|
|Altos Capital Partners|
|Silicon Valley Bank|
|Pfizer Venture Investments|
|Roche Venture Fund|